Advanced search
Publication Cover
Artificial Cells, Blood Substitutes, and Biotechnology Volume 30, 2002 - Issue 1
Journal homepage
634
Views
69
CrossRef citations to date
0
Altmetric
Original

CROSS-LINKED POLYHEMOGLOBIN-SUPEROXIDE DISMUTASE-CATALASE SUPPLIES OXYGEN WITHOUT CAUSING BLOOD BRAIN BARRIER DISRUPTION OR BRAIN EDEMA IN A RAT MODEL OF TRANSIENT GLOBAL BRAIN ISCHEMIA-REPERFUSION

D. Douglas Powanda Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, 3655 Drummond Street, Room 1006, Montreal, Quebec, H3G 1Y6, Canada
&
Thomas M.S. Chang Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, 3655 Drummond Street, Room 1006, Montreal, Quebec, H3G 1Y6, Canada
Pages 23-37 | Published online: 11 Jul 2009

Citations (69)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (17)

Thomas Ming Swi Chang. (2022) The role of artificial cells in the fight against COVID-19: deliver vaccine, hemoperfusion removes toxic cytokines, nanobiotherapeutics lower free radicals and pCO2 and replenish blood supply. Artificial Cells, Nanomedicine, and Biotechnology 50:1, pages 240-251.
Read now
Thomas Ming Swi Chang. (2019) ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 997-1013.
Read now
Chen Guo & Thomas Ming Swi Chang. (2018) Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion. Artificial Cells, Nanomedicine, and Biotechnology 46:7, pages 1349-1363.
Read now
Laura Terraneo, Paola Bianciardi, Ashok Malavalli, Gnel Mkrtchyan, Stephanie N. Spann, Jeff Lohman, Michele Samaja & Kim D. Vandegriff. (2017) Hemoglobin extravasation in the brain of rats exchange-transfused with hemoglobin-based oxygen carriers. Artificial Cells, Nanomedicine, and Biotechnology 45:4, pages 710-716.
Read now
Wenhua Jiang, Yuzhu Bian, Zhenghui Wang & Thomas Ming Swi Chang. (2017) Hepatoprotective effects of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] on alcohol-damaged primary rat hepatocyte culture in vitro. Artificial Cells, Nanomedicine, and Biotechnology 45:1, pages 46-50.
Read now
Y. Z. Bian, C. Guo & T. M. S. Chang. (2016) Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at −80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C. Artificial Cells, Nanomedicine, and Biotechnology 44:1, pages 41-47.
Read now
Thomas Ming Swi Chang. (2015) Red blood cell replacement, or nanobiotherapeutics with enhanced red blood cell functions?. Artificial Cells, Nanomedicine, and Biotechnology 43:3, pages 145-147.
Read now
Zhilan Xie, Lijun Liu, Wenjin Zhu, Huifang Liu, Li Wang, Jia Zhang, Chao Chen & Hongli Zhu. (2015) The protective effect of polymerized porcine hemoglobin (pPolyHb) on transient focal cerebral ischemia/reperfusion injury. Artificial Cells, Nanomedicine, and Biotechnology 43:3, pages 180-185.
Read now
C. Guo, M. Gynn & T. M. S. Chang. (2015) Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin–superoxide dismutase–catalase–carbonic anhydrase. Artificial Cells, Nanomedicine, and Biotechnology 43:3, pages 157-162.
Read now
Yuzhu Bian & Thomas Ming Swi Chang. (2015) A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume. Artificial Cells, Nanomedicine, and Biotechnology 43:1, pages 1-9.
Read now
Wei Gao, Yuzhu Bian & Thomas M.S. Chang. (2013) Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase. Artificial Cells, Nanomedicine, and Biotechnology 41:4, pages 232-239.
Read now
Vibhudutta Awasthi, Vivek R. Yadav, Beth Goins & William T. Phillips. (2013) Modulation of oxidative stability of haemoglobin inside liposome-encapsulated haemoglobin. Journal of Microencapsulation 30:5, pages 471-478.
Read now
Yuzhu Bian, Gao Wei & Thomas M. S. Chang. (2013) Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties. Artificial Cells, Nanomedicine, and Biotechnology 41:1, pages 60-68.
Read now
Hongli Zhu, Qianqian Du, Chao Chen & Thomas Ming Swi Chang. (2010) The Immunological Properties of Stroma-free Polyhemolysate Containing Catalase and Superoxide Dismutase Activities Prepared by Polymerized Bovine Stroma-free Hemolysate. Artificial Cells, Blood Substitutes, and Biotechnology 38:2, pages 57-63.
Read now
Wen-Hsiang Chang, Yen Chang, Yi-Chien Chen & Hsing-Wen Sung. (2004) Hemoglobin Polymerized with a Naturally Occurring Crosslinking Agent as a Blood Substitute: In Vitro and In Vivo Studies. Artificial Cells, Blood Substitutes, and Biotechnology 32:2, pages 243-262.
Read now
Thomas Ming Swi Chang. (2004) Artificial Cell Bioencapsulation in Macro, Micro, Nano, and Molecular Dimensions: Keynote Lecture. Artificial Cells, Blood Substitutes, and Biotechnology 32:1, pages 1-23.
Read now
Thomas Ming Swi Chang. (2003) Artificial Cells for Replacement of Metabolic Organ Functions. Artificial Cells, Blood Substitutes, and Biotechnology 31:2, pages 151-161.
Read now

Articles from other publishers (52)

Rongrong Liu, Wanjun Wang, Yaoxi Wang, Lili Zhang & Gang Chen. (2023) The Preliminary Study on Preparation Technology of PolyHb-SOD-CATCA - The Effects of Different Extractants. Current Pharmaceutical Biotechnology 24:15, pages 1928-1937.
Crossref
Thomas Ming Swi Chang. (2023) Editorial: Innovative medical technology based on artificial cells, including its different configurations. Frontiers in Medical Technology 5.
Crossref
Yuzhu Bian & Thomas Ming Swi Chang. (2023) Nanobiotechnological basis of an oxygen carrier with enhanced carbonic anhydrase for CO2 transport and enhanced catalase and superoxide dismutase for antioxidant function. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Serena Faggiano, Luca Ronda, Stefano Bruno, Stefania Abbruzzetti, Cristiano Viappiani, Stefano Bettati & Andrea Mozzarelli. (2022) From hemoglobin allostery to hemoglobin-based oxygen carriers. Molecular Aspects of Medicine 84, pages 101050.
Crossref
Thomas Ming Swi Chang. 2022. Blood Substitutes and Oxygen Biotherapeutics. Blood Substitutes and Oxygen Biotherapeutics 99 115 .
Jiwon Yeo, Junseok Lee, Sanggi Lee & Won Jong Kim. (2021) Polymeric Antioxidant Materials for Treatment of Inflammatory Disorders. Advanced Therapeutics 4:4.
Crossref
Clara Coll-Satue, Shahana Bishnoi, Jiantao Chen & Leticia Hosta-Rigau. (2021) Stepping stones to the future of haemoglobin-based blood products: clinical, preclinical and innovative examples. Biomaterials Science 9:4, pages 1135-1152.
Crossref
Thomas H. Edwards & Guillaume L. Hoareau. (2021) Fluids of the Future. Frontiers in Veterinary Science 7.
Crossref
梦媛 姜. (2021) Research Progress Based on Hemoglobin Oxygen Carrier. Advances in Analytical Chemistry 11:03, pages 144-152.
Crossref
Anirban Sen Gupta. 2021. Trauma Induced Coagulopathy. Trauma Induced Coagulopathy 719 743 .
Mengmeng Wang, Feilong Wang, Daiyin Peng, Xianchun Duan, Weidong Chen, Fan Xu & Lan Han. (2020) Tao-Hong Si-Wu Decoction Alleviates Cerebral Ischemic Damage in Rats by Improving Anti-oxidant and Inhibiting Apoptosis Pathway. International Journal of Pharmacology 16:3, pages 214-222.
Crossref
Donald A. Belcher, Clayton T. Cuddington, Evan L. Martindale, Ivan S. Pires & Andre F. Palmer. (2019) Controlled Polymerization and Ultrafiltration Increase the Consistency of Polymerized Hemoglobin for Use as an Oxygen Carrier. Bioconjugate Chemistry 31:3, pages 605-621.
Crossref
Michelle M.T. Jansman & Leticia Hosta-Rigau. (2018) Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers. Advances in Colloid and Interface Science 260, pages 65-84.
Crossref
Masayuki GekkaTakeo AbumiyaTeruyuki KomatsuRyosuke FunakiKota KurisuDaisuke ShimboMasato KawaboriToshiya OsanaiNaoki NakayamaKen KazumataKiyohiro Houkin. (2018) Novel Hemoglobin-Based Oxygen Carrier Bound With Albumin Shows Neuroprotection With Possible Antioxidant Effects. Stroke 49:8, pages 1960-1968.
Crossref
Anirban Sen Gupta. (2017) Bio‐inspired nanomedicine strategies for artificial blood components. WIREs Nanomedicine and Nanobiotechnology 9:6.
Crossref
Thomas Ming Swi Chang. 2013. Biomaterials Science. Biomaterials Science 811 827 .
Felice D’Agnillo. 2013. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics 665 682 .
Marie Grey, Khuanpiroon Ratanasopa & Leif Bülow. 2013. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics 349 358 .
Thomas Ming Swi Chang. 2013. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics 3 26 .
Huimin Qiao, Lipeng Dong, Xiangjian Zhang, Chunhua Zhu, Xiaolin Zhang, Lina Wang, Zongjie Liu, Linyu Chen, Yinxue Xing, Chaohui Wang & Yanhua Li. (2012) Protective Effect of Luteolin in Experimental Ischemic Stroke: Upregulated SOD1, CAT, Bcl-2 and Claudin-5, Down-Regulated MDA and Bax Expression. Neurochemical Research 37:9, pages 2014-2024.
Crossref
Thomas Chang. 2011. Nanomedicine and the Cardiovascular System. Nanomedicine and the Cardiovascular System 77 98 .
Venkatareddy NaditheYou Han Bae. (2011) Hemoglobin Conjugates with Antioxidant Enzymes (Hemoglobin-Superoxide Dismutase-Catalase) via Poly(Ethylene Glycol) Crosslinker for Protection of Pancreatic Beta RINm5F Cells in Hypoxia. Tissue Engineering Part A 17:19-20, pages 2453-2462.
Crossref
Taihang Li, Xiabin Jing & Yubin Huang. (2011) Polymer/Hemoglobin Assemblies: Biodegradable Oxygen Carriers for Artificial Red Blood Cells. Macromolecular Bioscience 11:7, pages 865-875.
Crossref
Venkatareddy Nadithe & You Han Bae. (2010) Synthesis and characterization of hemoglobin conjugates with antioxidant enzymes via poly(ethylene glycol) cross-linker (Hb–SOD–CAT) for protection from free radical stress. International Journal of Biological Macromolecules 47:5, pages 603-613.
Crossref
Thomas Ming Swi Chang. (2010) Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2:4, pages 418-430.
Crossref
M.ª Soledad Asuero & Trinidad Dorado. 2010. Tratado de Medicina Transfusional Perioperatoria. Tratado de Medicina Transfusional Perioperatoria 327 339 .
Marie Grey, Sakda Yainoy, Virapong Prachayasittikul & Leif Bülow. (2009) A superoxide dismutase–human hemoglobin fusion protein showing enhanced antioxidative properties. The FEBS Journal 276:21, pages 6195-6203.
Crossref
T.M.S. Chang. (2009) Nanobiotechnology for Hemoglobin-based Blood Substitutes. Critical Care Clinics 25:2, pages 373-382.
Crossref
Jong-Hoon Kim & Ki-Young Lee. (2009) Current Status and Future of Artificial Blood - Focusing on Red Blood Cell Substitutes. Journal of the Korean Medical Association 52:2, pages 168.
Crossref
Roman Kocian & Donat R. Spahn. (2008) Haemoglobin, oxygen carriers and perioperative organ perfusion. Best Practice & Research Clinical Anaesthesiology 22:1, pages 63-80.
Crossref
Y. Smani, P. Labrude, C. Vigneron & B. Faivre. (2007) Les transporteurs d’oxygène à base d’hémoglobine et les tentatives de substituer les globules rouges. Transfusion Clinique et Biologique 14:5, pages 464-473.
Crossref
Thomas Ming Swi Chang. 2007. Principles of Tissue Engineering. Principles of Tissue Engineering 749 758 .
Sarit Sivan & Noah Lotan. 2006. Wiley Encyclopedia of Biomedical Engineering. Wiley Encyclopedia of Biomedical Engineering.
Thomas Ming Swi Chang. 2006. Blood Substitutes. Blood Substitutes 451 459 .
Felice D’Agnillo. 2006. Blood Substitutes. Blood Substitutes 206 216 .
Jan A. Plock, Claudio Contaldo, Hiromi Sakai, Eishun Tsuchida, Michael Leunig, Andrej Banic, Michael D. Menger & Dominique Erni. (2005) Is hemoglobin in hemoglobin vesicles infused for isovolemic hemodilution necessary to improve oxygenation in critically ischemic hamster skin?. American Journal of Physiology-Heart and Circulatory Physiology 289:6, pages H2624-H2631.
Crossref
Robert Bartlett. 2005. Transfusion‐Free Medicine and Surgery. Transfusion‐Free Medicine and Surgery 254 282 .
Jun Mohara, Irene Aguilera, Bruce I. Goldman, Carol A. Fisher, John P. Gaughan, Joseph R. Libonati, Satoshi Furukawa & Arun K. Singhal. (2005) Effects of Nutrient and Hemoglobin Enriched Cell Free Perfusates Upon Ex Vivo Isolated Rat Heart Preparation. ASAIO Journal 51:3, pages 288-295.
Crossref
Thomas Ming Swi Chang. (2005) Therapeutic applications of polymeric artificial cells. Nature Reviews Drug Discovery 4:3, pages 221-235.
Crossref
M. Zouhair Atassi & Catherine Childress. (2005) Oxygen-binding Heme Complexes of Peptides Designed to Mimic the Heme Environment of Myoglobin and Hemoglobin. The Protein Journal 24:1, pages 37-49.
Crossref
Jan Simoni. 2005. Artificial Oxygen Carrier. Artificial Oxygen Carrier 75 126 .
Thomas Ming Swi Chang. 2005. Applications of Cell Immobilisation Biotechnology. Applications of Cell Immobilisation Biotechnology 249 255 .
Yubin Huang, Teruyuki Komatsu, Hisashi Yamamoto, Hirohisa Horinouchi, Koichi Kobayashi & Eishun Tsuchida. (2004) Safety Evaluation of an Artificial O2 Carrier as a Red Blood Cell Substitute by Blood Biochemical Tests and Histopathology Observations. ASAIO Journal 50:6, pages 525-529.
Crossref
Paul W. Buehler & Abdu I. Alayash. (2004) Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems. Transfusion 44:10, pages 1516-1530.
Crossref
Thomas Ming Swi Chang. (2004) Hemoglobin-based Red Blood Cell Substitutes. Artificial Organs 28:9, pages 789-794.
Crossref
Thomas Ming Swi Chang. (2004) Artificial Cells for Cell and Organ Replacements. Artificial Organs 28:3, pages 265-270.
Crossref
Thomas Ming Swi Chang. (2004) A new red blood cell substitute *. Critical Care Medicine 32:2, pages 612-613.
Crossref
Abdu I. Alayash. (2004) Oxygen therapeutics: can we tame haemoglobin?. Nature Reviews Drug Discovery 3:2, pages 152-159.
Crossref
Jacques Creteur & Jean-Louis Vincent. (2003) Hemoglobin solutions. Critical Care Medicine 31:Supplement, pages S698-S707.
Crossref
Claudio Contaldo, Sören Schramm, Reto Wettstein, Hiromi Sakai, Shinji Takeoka, Eishun Tsuchida, Michael Leunig, Andrej Banic & Dominique Erni. (2003) Improved oxygenation in ischemic hamster flap tissue is correlated with increasing hemodilution with Hb vesicles and their O 2 affinity . American Journal of Physiology-Heart and Circulatory Physiology 285:3, pages H1140-H1147.
Crossref
Thomas J. Reid. (2003) Hb‐based oxygen carriers: are we there yet?. Transfusion 43:2, pages 280-287.
Crossref
Harvey S. Borovetz, John F. Burke, Thomas Ming Swi Chang, André Colas, A. Norman Cranin, Jim Curtis, Cynthia H. Gemmell, Bartley P. Griffith, Nadim James Hallab, Jorge Heller, Allan S. Hoffman, Joshua J. Jacobs, Ray Ideker, J. Lawrence Katz, Jack Kennedy, Jack E. Lemons, Paul S. Malchesky, Jeffery R. Morgan, Robert E. PaderaJr.Jr., Anil S. Patel, Miguel F. Reffojo, Mark S. Roby, Thomas E. Rohr, Frederick J. Schoen, Michael V. Sefton, Robert T. Sheridan, Dennis C. Smith, Francis A. Spelman, Peter J. Tarcha, Ronald G. Tomapkins, Ramakrishna Venugopalan, William R. Wagner, Paul Yager & Martin L. Yarmush. 1996. Biomaterials Science. Biomaterials Science 455 XVI .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.